NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution

L. E. Arnold, H. B. Abikoff, D. P. Cantwell, C. K. Conners, G. R. Elliott, L. L. Greenhill, L. Hechtman, S. P. Hinshaw, B. Hoza, P. S. Jensen, H. C. Kraemer, J. S. March, J. H. Newcorn, W. E. Pelham, J. E. Richters, E. Schiller, J. B. Severe, J. M. Swanson, D. Vereen, K. C. Wells

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The steering committee of the collaborative six-site Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (the MTA) had to develop a common protocol consistent with public health goals and with scientific and clinical state of the art. With the aid of statistical, educational, and public health consultation, the steering committee balanced the stated objectives of the RFA against budgetary, clinical, ethical, and logistical practicalities. Two primary questions will be addressed: (1) What is the relative long-term effectiveness of excellent medication vs. excellent behavioral treatment vs. the combination? (2) What is the relative long-term effectiveness of each of these state-of-the art intense treatments vs. routine community care? In a parallel-group design, 576 children (96 at each site) age 7-9 in grades 1-4 are thoroughly assessed in multiple domains from multiple informants and randomized to 4 treatment conditions: a medication-alone strategy, a psychosocial-treatment-alone strategy, a combination strategy, and community comparison (assessment and referral). The first three groups are treated for 14 months and all are re-assessed periodically for 24 months. Each treatment strategy is multi-component, with compromises between clinical flexibility and cross-site uniformity supported by a multi-tiered supervisory/fidelity structure, including 10 manuals, weekly teleconference panels, site visits, circuit-riding consultants, and feedback loops from therapists and supervisors to the steering committee about clinical realities. The resulting data should not only answer the primary questions above, but also support secondary data analyses about the effect of comorbidity, sex, SES, and other subject characteristics on treatment outcome. The MTA should both provide conclusions useful to the practicing clinician and define questions for the next generation of investigations.

Original languageEnglish (US)
Pages (from-to)141-158
Number of pages18
JournalJournal of Attention Disorders
Volume2
Issue number3
StatePublished - Oct 1997
Externally publishedYes

Fingerprint

Pemetrexed
National Institute of Mental Health (U.S.)
Combined Modality Therapy
Referral and Consultation
Public Health
Therapeutics
Telecommunications
Attention Deficit Disorder with Hyperactivity
Consultants
Comorbidity

ASJC Scopus subject areas

  • Psychology(all)

Cite this

Arnold, L. E., Abikoff, H. B., Cantwell, D. P., Conners, C. K., Elliott, G. R., Greenhill, L. L., ... Wells, K. C. (1997). NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution. Journal of Attention Disorders, 2(3), 141-158.

NIMH collaborative multimodal treatment study of children with ADHD (MTA) : Design, methodology, and protocol evolution. / Arnold, L. E.; Abikoff, H. B.; Cantwell, D. P.; Conners, C. K.; Elliott, G. R.; Greenhill, L. L.; Hechtman, L.; Hinshaw, S. P.; Hoza, B.; Jensen, P. S.; Kraemer, H. C.; March, J. S.; Newcorn, J. H.; Pelham, W. E.; Richters, J. E.; Schiller, E.; Severe, J. B.; Swanson, J. M.; Vereen, D.; Wells, K. C.

In: Journal of Attention Disorders, Vol. 2, No. 3, 10.1997, p. 141-158.

Research output: Contribution to journalArticle

Arnold, LE, Abikoff, HB, Cantwell, DP, Conners, CK, Elliott, GR, Greenhill, LL, Hechtman, L, Hinshaw, SP, Hoza, B, Jensen, PS, Kraemer, HC, March, JS, Newcorn, JH, Pelham, WE, Richters, JE, Schiller, E, Severe, JB, Swanson, JM, Vereen, D & Wells, KC 1997, 'NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution', Journal of Attention Disorders, vol. 2, no. 3, pp. 141-158.
Arnold LE, Abikoff HB, Cantwell DP, Conners CK, Elliott GR, Greenhill LL et al. NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution. Journal of Attention Disorders. 1997 Oct;2(3):141-158.
Arnold, L. E. ; Abikoff, H. B. ; Cantwell, D. P. ; Conners, C. K. ; Elliott, G. R. ; Greenhill, L. L. ; Hechtman, L. ; Hinshaw, S. P. ; Hoza, B. ; Jensen, P. S. ; Kraemer, H. C. ; March, J. S. ; Newcorn, J. H. ; Pelham, W. E. ; Richters, J. E. ; Schiller, E. ; Severe, J. B. ; Swanson, J. M. ; Vereen, D. ; Wells, K. C. / NIMH collaborative multimodal treatment study of children with ADHD (MTA) : Design, methodology, and protocol evolution. In: Journal of Attention Disorders. 1997 ; Vol. 2, No. 3. pp. 141-158.
@article{e15f43068b394f35b7f48a3a6610c4ef,
title = "NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution",
abstract = "The steering committee of the collaborative six-site Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (the MTA) had to develop a common protocol consistent with public health goals and with scientific and clinical state of the art. With the aid of statistical, educational, and public health consultation, the steering committee balanced the stated objectives of the RFA against budgetary, clinical, ethical, and logistical practicalities. Two primary questions will be addressed: (1) What is the relative long-term effectiveness of excellent medication vs. excellent behavioral treatment vs. the combination? (2) What is the relative long-term effectiveness of each of these state-of-the art intense treatments vs. routine community care? In a parallel-group design, 576 children (96 at each site) age 7-9 in grades 1-4 are thoroughly assessed in multiple domains from multiple informants and randomized to 4 treatment conditions: a medication-alone strategy, a psychosocial-treatment-alone strategy, a combination strategy, and community comparison (assessment and referral). The first three groups are treated for 14 months and all are re-assessed periodically for 24 months. Each treatment strategy is multi-component, with compromises between clinical flexibility and cross-site uniformity supported by a multi-tiered supervisory/fidelity structure, including 10 manuals, weekly teleconference panels, site visits, circuit-riding consultants, and feedback loops from therapists and supervisors to the steering committee about clinical realities. The resulting data should not only answer the primary questions above, but also support secondary data analyses about the effect of comorbidity, sex, SES, and other subject characteristics on treatment outcome. The MTA should both provide conclusions useful to the practicing clinician and define questions for the next generation of investigations.",
author = "Arnold, {L. E.} and Abikoff, {H. B.} and Cantwell, {D. P.} and Conners, {C. K.} and Elliott, {G. R.} and Greenhill, {L. L.} and L. Hechtman and Hinshaw, {S. P.} and B. Hoza and Jensen, {P. S.} and Kraemer, {H. C.} and March, {J. S.} and Newcorn, {J. H.} and Pelham, {W. E.} and Richters, {J. E.} and E. Schiller and Severe, {J. B.} and Swanson, {J. M.} and D. Vereen and Wells, {K. C.}",
year = "1997",
month = "10",
language = "English (US)",
volume = "2",
pages = "141--158",
journal = "Journal of Attention Disorders",
issn = "1087-0547",
publisher = "SAGE Publications Inc.",
number = "3",

}

TY - JOUR

T1 - NIMH collaborative multimodal treatment study of children with ADHD (MTA)

T2 - Design, methodology, and protocol evolution

AU - Arnold, L. E.

AU - Abikoff, H. B.

AU - Cantwell, D. P.

AU - Conners, C. K.

AU - Elliott, G. R.

AU - Greenhill, L. L.

AU - Hechtman, L.

AU - Hinshaw, S. P.

AU - Hoza, B.

AU - Jensen, P. S.

AU - Kraemer, H. C.

AU - March, J. S.

AU - Newcorn, J. H.

AU - Pelham, W. E.

AU - Richters, J. E.

AU - Schiller, E.

AU - Severe, J. B.

AU - Swanson, J. M.

AU - Vereen, D.

AU - Wells, K. C.

PY - 1997/10

Y1 - 1997/10

N2 - The steering committee of the collaborative six-site Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (the MTA) had to develop a common protocol consistent with public health goals and with scientific and clinical state of the art. With the aid of statistical, educational, and public health consultation, the steering committee balanced the stated objectives of the RFA against budgetary, clinical, ethical, and logistical practicalities. Two primary questions will be addressed: (1) What is the relative long-term effectiveness of excellent medication vs. excellent behavioral treatment vs. the combination? (2) What is the relative long-term effectiveness of each of these state-of-the art intense treatments vs. routine community care? In a parallel-group design, 576 children (96 at each site) age 7-9 in grades 1-4 are thoroughly assessed in multiple domains from multiple informants and randomized to 4 treatment conditions: a medication-alone strategy, a psychosocial-treatment-alone strategy, a combination strategy, and community comparison (assessment and referral). The first three groups are treated for 14 months and all are re-assessed periodically for 24 months. Each treatment strategy is multi-component, with compromises between clinical flexibility and cross-site uniformity supported by a multi-tiered supervisory/fidelity structure, including 10 manuals, weekly teleconference panels, site visits, circuit-riding consultants, and feedback loops from therapists and supervisors to the steering committee about clinical realities. The resulting data should not only answer the primary questions above, but also support secondary data analyses about the effect of comorbidity, sex, SES, and other subject characteristics on treatment outcome. The MTA should both provide conclusions useful to the practicing clinician and define questions for the next generation of investigations.

AB - The steering committee of the collaborative six-site Multimodal Treatment Study of Children with Attention-Deficit/Hyperactivity Disorder (the MTA) had to develop a common protocol consistent with public health goals and with scientific and clinical state of the art. With the aid of statistical, educational, and public health consultation, the steering committee balanced the stated objectives of the RFA against budgetary, clinical, ethical, and logistical practicalities. Two primary questions will be addressed: (1) What is the relative long-term effectiveness of excellent medication vs. excellent behavioral treatment vs. the combination? (2) What is the relative long-term effectiveness of each of these state-of-the art intense treatments vs. routine community care? In a parallel-group design, 576 children (96 at each site) age 7-9 in grades 1-4 are thoroughly assessed in multiple domains from multiple informants and randomized to 4 treatment conditions: a medication-alone strategy, a psychosocial-treatment-alone strategy, a combination strategy, and community comparison (assessment and referral). The first three groups are treated for 14 months and all are re-assessed periodically for 24 months. Each treatment strategy is multi-component, with compromises between clinical flexibility and cross-site uniformity supported by a multi-tiered supervisory/fidelity structure, including 10 manuals, weekly teleconference panels, site visits, circuit-riding consultants, and feedback loops from therapists and supervisors to the steering committee about clinical realities. The resulting data should not only answer the primary questions above, but also support secondary data analyses about the effect of comorbidity, sex, SES, and other subject characteristics on treatment outcome. The MTA should both provide conclusions useful to the practicing clinician and define questions for the next generation of investigations.

UR - http://www.scopus.com/inward/record.url?scp=0001464360&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0001464360&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0001464360

VL - 2

SP - 141

EP - 158

JO - Journal of Attention Disorders

JF - Journal of Attention Disorders

SN - 1087-0547

IS - 3

ER -